Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @translationalpk
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @translationalpk
-
Translational PK Research Group proslijedio/la je Tweet
Taking delivery of two LC-MS/MS was a fantastic way to end 2019
@translationalpk@OAUniversity. These will totally transform bioanalytical capability in Nigeria and in the region. Big thank you to collaborators@livuniITM.pic.twitter.com/7cfeZeS9zW
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Translational PK Research Group proslijedio/la je TweetHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
Translational PK Research Group proslijedio/la je Tweet
ONGOING: One-week (11-15 Nov 2019) training course on popPK modeling
@OAUniversity. Participants from Ghana, Nigeria & South Africa being taught by Prof. Leon Aaron & Dr Kay Ogungbenro of@OfficialUoM, and Dr Paolo Denti & Mahmoud Abdelwahab of@UCT_news. By PMxAfrica@colpilPrikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
WCoP 2020 will support eligible young and established scientists with scholarships to cover travel & accommodation expenses. See https://wcop2020.org/travel-bursaries/ ….
@WCoP2020pic.twitter.com/xm1wZxXoV9
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
[Upcoming Webinar]: Exploratory & Noncompartmental Analyses of PK/PD Data. Pharmacometrics Africa and partners are excited to announce this live webinar on 4th November 2019 at 3:00 pm GMT. It will be presented by Dr Samer Mouksassi. Register here: https://zoom.us/meeting/register/b8ab4498a46e8f1b8c34be5db4a05ad8 …pic.twitter.com/R2y0gGO01J
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Translational PK Research Group proslijedio/la je Tweet
Dolutegravir-based regimen noninferior to an efavirenz 400mg-based reference regimen with regard to viral suppression at week 48. But for patients with 100,000 copies/mL or more at baseline, fewer than expected had viral suppression
@NEJM@UNITAID. https://www.nejm.org/doi/10.1056/NEJMoa1904340 …pic.twitter.com/hp24Zj7tz0
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Translational PK Research Group proslijedio/la je Tweet
I recommend this e-course for students, researchers and clinicians interested in learning more about pharmacometrics. It is well paced and fun too. In addition, you enjoy the luxury of top-notch experts to guide you through the entire learning process.1https://twitter.com/ShakirAtoyebi/status/1155552234018607105 …
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Dolutegravir achieves more rapid virological suppression before delivery compared to efavirenz when initiated in late pregnancy. Regardless of arm, late presentation in pregnancy is associated with poor outcomes despite ART. http://www.croiconference.org/sessions/rct-dolutegravir-vs-efavirenz-based-therapy-initiated-late-pregnancy-dolphin-2 ….
@CatrionaWaitt#CROI2019Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
DOUBLE-DOSE LEVONORGESTREL IMPLANT DOES NOT FULLY OVERCOME INTERACTION WITH EFAVIRENZ. http://www.croiconference.org/sessions/double-dose-levonorgestrel-implant-does-not-fully-overcome-interaction-efavirenz …
@siccardi_marco@daveback01#CROI2019Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
Moments from
#PBPKCourseNigeria2018. We're now looking forward to inviting participants to the next course.pic.twitter.com/O1TIsh1lYM
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Translational PK Research Group proslijedio/la je Tweet
A small number of people living with
#HIV known as “HIV controllers” can control the virus without needing antiretroviral treatment. A new study in@jiasociety explores the factors implicated in the development of HIV among HIV controllers http://ow.ly/n8S430ngUYN pic.twitter.com/zwDJLwELVp
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Translational PK Research Group proslijedio/la je Tweet
A
#CRISPR study has revealed new genes that help regulate the immune system, and created a map of T cell regulation. This could help scientists develop drugs to activate the#immune system against#tumours or#infection in the future.https://bit.ly/2smSjspHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Translational PK Research Group proslijedio/la je Tweet
We need more statisticians to
#peerreview#NIHR-funded research. Could you help? http://ow.ly/hVbv30nbZYA pic.twitter.com/Mn8lU3Ve0M
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Translational PK Research Group proslijedio/la je Tweet
@AASciences has endorsed the progressive open publishing position, Plan S, of the European Union.Plan S is an initiative for open access publishing that was launched in September 2018
http://bit.ly/2TORJiX Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Translational PK Research Group proslijedio/la je Tweet
According to new
@PEPFAR-supported survey data,#Nigeria may be closer to achieving#HIV epidemic control than was previously thought, with most Nigerians who report being on HIV#treatment having suppressed their viral replication.Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Full text available here: https://bpspubs.onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.13821 …. Many thanks to HIV Research Trust & Novartis Pharma AG for funding that made this work possible, and to our collaborators
@livuniITM for access to the Liverpool Bioanalytical Facility.@aeolagunjuPrikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
...increased from 10% without artemether-lumefantrine (all extensive metabolisers) to 21% with artemether-lumefantrine (14% extensive, 4% intermediate, and 3% poor metabolisers).
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
No clinically significant changes were observed in key nevirapine PK parameters, the 90% CI falling completely within the 0.80-1.25 no-effect boundaries. However, # of patients with trough plasma nevirapine concentration below the 3,400 ng ml-1 minimum effective concentration..
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.